Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks
- DOI
- 10.6082/e3tsm-s1v23
- Published
- 2022
- Container
- Not recorded
- Publisher
- University of Chicago
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.6082/e3tsm-s1v23,
title = {Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks},
author = {Sudhakar, Deepshika and Huang, Zhong and Zietkowski, Maeson and Powell, Natasha and Fisher, Andrew R.},
year = {2022},
doi = {10.6082/e3tsm-s1v23},
url = {https://doi.org/10.6082/e3tsm-s1v23}
}RIS
TY - JOUR TI - Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks AU - Sudhakar, Deepshika AU - Huang, Zhong AU - Zietkowski, Maeson AU - Powell, Natasha AU - Fisher, Andrew R. PY - 2022 DO - 10.6082/e3tsm-s1v23 UR - https://doi.org/10.6082/e3tsm-s1v23 ER -
APA
Deepshika, S., Zhong, H., Maeson, Z., Natasha, P., & R., F. A. (2022). Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks. https://doi.org/10.6082/e3tsm-s1v23